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1. Introduction 
The high prevalence of cardiovascular disease (CVD) in the past 50 years has led to intense 
research, resulting in many improvements in treatment. At the same time, type 2 diabetes, 
with its concomitant increase in vascular complications, has become a serious, exploding, 
and costly public health concern (1;2). 
Diabetes now affects 285 million adults worldwide and 344 million with pre-diabetes. Of 
these, 25.8 million diabetics and 79 million pre-diabetics are found in the United States alone 
(3). 
The current cost of diabetes in the US is likely to exceed the $174 billion estimate, which 
includes 2/3 for direct medical costs and 1/3 for indirect costs, such as disability, work loss, 
and premature death, but omits the social cost of intangibles (e.g. pain, suffering, lower 
quality of life) (4-6). 
The diabetes epidemic has been accompanied by a similarly drastic increase in obesity. 
Although the relationship between the two developments is a matter of debate, both are 
presumably caused by changes in dietary habits and an increasingly sedentary modern 
lifestyle (7;8). Compelling evidence has shown that lifestyle changes can effectively prevent 
or delay the occurrence of type 2 diabetes (9-12).  
Because individuals at risk for this disease can usually be identified during the pre-diabetic 
phase of impaired glucose tolerance, early intervention and lifestyle change offer a logical 
approach to preventing this disease and its devastating vascular complications (13).  
Additionally, community-based lifestyle interventions for high risk groups and for the 
general population are a cost-effective way of curbing the growing burden of the disease 
(14).  
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Solidifying the scientific basis for the prevention, treatment and control of this disease and 
its implementation on a national level, however, remains a difficult challenge (15;16). More 
research is needed to provide comprehensive and more effective strategies for weight-loss, 
especially over time (17;18). 
Therefore, the objectives of this study were to identify diabetics and those at risk (pre-
diabetics) out of the total cohort of 1,517 who selected themselves into an intensive 
community-based lifestyle intervention program, and to assess its clinical efficacy in 
effecting medication status as determined and managed by their personal physicians. 
2. Methods 
CHIP is a 4-week, community-based intensive educational lifestyle intervention program. 
The project is designed to assess the extent to which a self-selected population can 
contribute to a shift in coronary risk factors in the community-at-large aiming at primary 
and secondary prevention.  
The participants were recruited from the general population through presentations at 
service clubs, churches, corporations, as well as through media exposure, billboards, 
brochures, and healthcare providers.  
To be included in the program, participants had to be at least 21 years of age, free of current 
cancer treatment, at least 3 months post bypass surgery, not afflicted by alcoholism, and able 
to engage in walking exercises. Eligible and interested participants provided informed 
consent. All participants were advised to work closely with their personal physicians to 
monitor clinical changes and to facilitate medication adjustments.  
The 40-hour educational intervention with behavioral and skill development content 
consisted of a carefully crafted 16-session series offered Monday through Thursday for 2 
hours over a 4-week period (for details please see Englert et al (19)). Through these almost 
daily meetings with lectures, clinical Q & A sessions and reading assignments (syllabus, 
text- and workbooks), the participants became acquainted with some of the extensive 
epidemiological literature describing the importance of lifestyle factors in the etiology and 
treatment of chronic circulatory diseases with a focus on a simpler, more Optimal Diet used 
ad libitum (20). In addition, several workshops (cooking classes, food-shopping tours, and 
clinical breakout sessions) were offered during the program to provide the skills needed for 
adopting a simpler diet. The workshops emphasized the importance of consuming more 
whole foods, such as fruits and vegetables, legumes and whole-grain products as a way to 
facilitate lower energy intake with reduced fat (≤20% of total calories), cholesterol (≤50 mg), 
salt (≤5 gm), and refined sugar, and enhanced fiber content (>30 to 40 gm) (for details please 
see Englert et al (21)). Furthermore, the CHIP program promoted smoking cessation and 
recommended a daily exercise program consisting of 30 minutes of walking and general 
fitness. At the end of the program, participants were encouraged to join the Rockford CHIP 
Alumni Organization and attend the monthly educational and support meetings for 
maintenance. 
Prior to the educational intervention, all participants underwent blood testing for fasting 
glucose and lipid levels, and filled out standardized questionnaires on food and tabacco habits 
and physical activity. The second biometric assessment took place at the conclusion of the 4-
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week program. Patients were screened, questionnaires were completed and blood was drawn 
by the same trained clinical team to assure standardized procedure for quality control. 
As part of the “before” and “after” screening, participants were required to complete a 
lifestyle/nutrition knowledge test and to fill out personal lifestyle evaluation forms, which 
included a self-reported medical history, socio-economic details, food-frequency diary, 
stress level, smoking history, and exercise inventory.  
The clinical definitions used for fasting glucose levels are set by the American Diabetes 
Association (22): normal glucose: <100mg/dl; pre-diabetes: 100 to 125 mg/dl; diabetes: >125 
mg/dl. 
Weekly physical activity was assessed by frequency and duration of exercise during a usual 
week: sedentary lifestyle score 0 (no exercise or at the most 2 times/week for 30 minutes or less 
than 13 min/day); moderate score 1 (3 to 5 times/week physical activity for 30 minutes or 
between 13 and 22 min/day); optimal score 2 (6 to 7 times/week physical activity for 30 
minutes or more than 22 min/day) (23). 
2.1 Statistical analyses 
The following data are from the consolidation phase of the Rockford CHIP research project 
(19). From the fall of 2000 to the fall of 2002, we conducted 5 CHIP programs, with an 
average enrollment of 300 per program. Out of a total of 1,569 participants, 52 did not meet 
the graduation criteria, leaving a cohort of 1,517 men and women for this analysis. In the 
subgroup analysis presented here, we focused on 758 participants with pre-diabetes and 
type 2 diabetes (21).  
Before each lecture, participants signed in at the registration desk. Those who attended 
fewer than 13 of the 16 meetings or failed to provide complete clinical data sets did not meet 
the graduation requirements (drop-outs), and their data were not included in this analysis.  
Data were entered twice for accuracy and then analyzed using SPSS 13.0. After testing for 
homogeneity, the 5 datasets were pooled and analyzed. Paired t tests were used to detect 
before and after changes as continuous variables. McNemar tests were performed for 
categorical variables and 2 –tests for differences in men and women at baseline and after 4 
weeks. Analysis of covariance was performed with fasting glucose changes as the 
dependent variable, and gender, age, and changes in weight (BMI), triglycerides, and 
physical activity as independent variables. 
3. Results 
The socio-demographic characteristics of the 758 pre-diabetics and diabetics are presented in 
Table 1. The gender composition was 432 women and 326 men. The age span ranged from 
21 to 81 years. The average age for men was 58 (SD 11) and for women 56 (SD 11). Because 
no correlation was found between risk improvement and age, data were not age adjusted. 
Table 2 depicts the profile of the cohort with reference to diabetes-related risk factors at 
admission. Of these, 69% were classified as pre-diabetics and 31% as type 2 diabetics, 29% 
were overweight (BMI between 26 and 30), and 59% were obese (BMI >30). 74% reported a 
sedentary lifestyle. 
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 Total (N=758) 
Gender 
Age (yrs) 
Marital status 
 married  
 single 
 divorced 
 widowed 
Education 
 < 12 years 
 12 years 
 some college 
 college or more 
43% men, 57% women 
58 yrs (men), 56 yrs (women)  
 
81% 
6% 
7% 
6% 
 
6% 
21% 
59% 
14% 
Table 1. Socio-demographics: the Rockford CHIP (Illinois, USA)  
 
 Men  
(N=326) 
Women  
(N=432) 
Total  
(N=758) 
Age ≥45 years 
Pre-diabetes (Glucose 100 to 125 mg/dl) 
Diabetes (Glucose >125 mg/dl and/or on 
hypoglycemic medication) 
Overweight (BMI between 26 and 30) 
Obese (BMI >30) 
Hypertension (SBP ≥130 or DBP ≥ 
85mmHg and/or on antihypertensive 
medication) 
Triglycerides (≥250 mg/dl) 
LDL Cholesterol (LDL ≥100 mg/dl 
and/or on hypolipidemic medication) 
Sedentary Lifestyle 
91% 
66% 
34% 
 
32% 
57% 
87% 
 
 
20% 
90% 
 
67% 
89% 
71% 
29% 
 
26% 
61% 
79% 
 
 
15% 
86% 
 
79% 
90% 
69% 
31% 
 
29% 
59% 
83% 
 
 
17% 
88% 
 
74% 
 
Table 2. Diabetes related risk factors of pre-diabetics and diabetics at admission: the 
Rockford CHIP (Illinois, USA) 
Figure 1 shows the flow diagram of the total cohort with reference to pre-diabetes and 
diabetes after the initial screening. Out of the total cohort of 758 participants, 521 (69%) were 
classified as pre-diabetics and 237 (31%) as type 2 diabetics. Among the latter group, 154 
persons were on medication. A significant number of the 83 diabetic subjects not receiving 
medication were unaware of their condition. The effects of the CHIP lifestyle intervention 
program on fasting glucose levels in these participants not taking medication with pre-
diabetes (n=521) and type 2 diabetes (n=83) can be seen in figure 2. Glucose levels improved 
significantly in both pre-diabetics and diabetics - the higher the initial glucose, the greater 
the glucose reduction. In many cases, diabetic glucose levels were brought down into the 
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normal range. Among the pre-diabetics, 47% (25% women and 22% men) were able to lower 
their glucose below 100mg/dl. 
 
Fig. 1. Flow Diagram according to baseline assessment: the Rockford CHIP (Illinois, USA) 
Tables 3 and 4 present the mean changes in fasting glucose in subjects receiving medication 
(oral hypoglycemics and/or insulin), stratified by gender and medication changes. 44% of 
those on oral drugs and 42% of those on insulin were advised by their personal physician to 
reduce their daily medication dosage. In participants whose glucose levels were initially 
above 125 mg/dl, glucose levels improved on the average between 38 to 49 mg/dl in men 
and 22 to 27 mg/dl in women. In diabetics with initial levels >125 mg/dl whose medication 
dosage remained the same, the reductions in glucose levels were equally impressive: the 
average reduction in men was from 18 mg/dl to 43 mg/dl and in women from 39 to 42 
mg/dl. Of those 19 diabetics taking both insulin and drugs, 15 participants were able to 
reduce their daily doses even so glucose levels dropped by 8 mg/dl and 67 mg/dl in 
women and men, respectively. 
35% of the diabetics were able to reduce their glucose levels below 125 mg/dl. Of these 
individuals, 10% were even able to reduce them to below 100 mg/dl. 
Triglyceride levels in women dropped significantly from 171 mg/dl to 163 mg/dl, and in 
men from 182mg/dl to 147 mg/dl. LDL levels in women dropped from 122 mg/dl to 112 
mg/dl and from 118 mg/dl to 96 mg/dl in men. Moreover average, systolic and diastolic 
blood pressure was reduced from 140/85 mmHg to 133/79 mmHg in women and 141/85 to 
132/80 mmHg in men. 
During the 4-week CHIP program, the mean weight reduction was 9 pounds for men and 7 
pounds for women. Figure 3 shows that those who needed to lose the most weight lost the 
most.  
www.intechopen.com
 Primary Care at a Glance – Hot Topics and New Insights 
 
328 
 Men (n=57) Women (n=57) 
 Means Means 
 before after change before after change 
Glucose (mg/dl) 
drug dosage reduction*  
≤125 (n=12) 
>125 (n=38) 
drug dosage 
unchanged 
≤125 (n=18) 
>125 (n=46) 
 
 
108 
166 
 
 
114 
178 
 
 
123 
128 
 
 
109 
135 
 
 
+15 
-38 
 
 
-5 
-43 
 
 
109 
175 
 
 
114 
189 
 
 
118 
153 
 
 
112 
150 
 
 
+9 
-22 
 
 
-2 
-39 
* reductions: more than 10% of the daily dose 
Table 3. Mean changes over 4 weeks in fasting glucose in diabetics on oral drugs by gender 
(n=114), according to admission levels: the Rockford CHIP (Illinois, USA)  
 Men (n=28) Women (n=31) 
 Means Means 
 before after change before after change 
Glucose (mg/dl) 
Insulin dosage 
reductions*  
≤ 125 (n=7) 
> 125 (n=18) 
Insulin dosage 
unchanged 
≤ 125 (n=6) 
> 125 (n=28) 
 
 
 
112 
174 
 
 
121 
136 
 
 
 
107 
125 
 
 
105 
118 
 
 
 
-5 
-49 
 
 
-16 
-18 
 
 
 
114 
178 
 
 
110 
131 
 
 
 
112 
151 
 
 
106 
89 
 
 
 
-2 
-27 
 
 
-4 
-42 
* reductions: more than 10% of the daily dose 
Table 4. Mean changes over 4 weeks in fasting glucose in diabetics on insulin by gender 
(n=59), according to admission levels: the Rockford CHIP (Illinois, USA) 
Figure 4 shows significant improvements in physical activity. At the beginning of the 
intervention, 79% of women and 67% of men reported little or no physical activity, 19% and 
28% reported engaging in moderate exercise, and 2% and 5% reported engaging in optimal 
physical activity. After the 4-week program, only 38% of women and 31% of men reported 
little or no physical activity, 54% and 58% reported moderate physical activity, and 8% and 
12% optimal physical activity.  
The Analysis of Covariance for glucose changes in participants with pre-diabetes and type 2 
diabetes showed significant results for gender (p≤0.001), BMI (p≤0.001), and triglycerides 
(p≤0.001) but not for physical activity. Improvements in weight and blood glucose were 
significantly higher in men than in women. In general, after adjusting for gender, reductions 
in blood glucose were positively related to weight loss - the higher the weight loss, the 
greater the improvement in blood glucose.  
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Fig. 2. Mean changes over 4 weeks in fasting glucose in pre-diabetics (n=83) and diabetics 
(n=521) not on medication: the Rockford CHIP (Illinois, USA) 
 
Fig. 3. Mean changes over 4 weeks in weight (pounds) in pre-diabetics (n=521) and diabetics 
(n=237): the Rockford CHIP (Illinois, USA) 
www.intechopen.com
 Primary Care at a Glance – Hot Topics and New Insights 
 
330 
 
Fig. 4. Changes (in %) over 4 weeks in physical activity in pre-diabetics and diabetics 
(N=758): the Rockford CHIP (Illinois, USA) 
4. Discussion 
Primary and secondary prevention of type 2 diabetes is the most promising way to alleviate 
the ever-growing global burden of this disease (24-26). The aim of this community-based 
CHIP program was thus to translate theoretical knowledge on the subject into well-defined, 
real-world strategies for screening and treating a population high at risk for type 2 diabetes.  
5. Diabetes risk profile 
Half of the total cohort of the CHIP consolidation phase (n=1,517) had already or was at risk 
for diabetes. This sub analysis showed that 35% of the diabetics had never been diagnosed 
or received diabetes treatment previously. High rates in diabetes related risk factors such as 
overweight/obesity (88%), hypertension (83%) and LDL-Cholesterol (88%) is most likely an 
expression of individual lifestyle choices and the interaction with the environment.  
6. Effects of CHIP  
CHIP led to an improved risk profile in this high risk patient group. Glucose levels in the 
pre-diabetics and diabetics who were not on medication improved between 5 mg/dl and 30 
mg/dl depending on gender and baseline values.  
Similar reductions were observed in the 154 participants who were taking diabetes medication. 
It is noteworthy that these changes in fasting glucose made it possible – under physicians’ 
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supervision – to reduce the dose of diabetes medication in approximately 40% of cases. 
Despite this dosage reduction, the decrease in glucose levels was clinically relevant in the 
majority of diabetics. Eliminating or reducing the intake of these medications is desirable from 
both a medical and health economic perspective because of their side effects and costs (27).  
7. Critical factors of success of the CHIP program  
CHIP focuses mainly on 5 process steps: 1) Identification and enrollment of participants 
with type 2 diabetes or high at risk. 2) Risk profile assessment (HeartScreen-examination). 3) 
Behavior change (intense, flexible, culturally sensitive, and individualized 16-lesson 
curriculum that covers diet, exercise, and behavioral modification). 4) Behavior maintenance 
(alumni groups and supportive community). 5) Evaluation. 
7.1 Lifestyle changes 
Diet and exercise: There is little discrepancy about the fact that exercise and weight loss play a 
vital role in the treatment of pre-diabetes and diabetes. Both have been shown to improve 
insulin resistance and hyperglycemia (16). A review by Miller & Dustan summarizes data on 
the effectiveness of physical-activity interventions for treating overweight/obesity and type 
2 diabetes. Most of the reported exercise-based interventions have been conducted in clinical 
settings; and they have often required the use of extensive resources (28). In the CHIP-study 
we recommended a minimum regimen of 30 min/day of moderate-intensity exercise, such 
as brisk walking (which harmonizes well the recommendations from the American Diabetes 
Association (ADA) and also the American Association of Clinical Endocrinologists (AACE). 
There was a significant improvement in physical activity levels in both men and women. In 
total, 46% of the participants reported that they had increased their level of physical activity 
to at least 30 minutes a day, or 210 minutes a week. It is noteworthy that, at the beginning of 
the program, 74% of participants reported no physical activity at all, while at the end only 
35% were physically inactive. Tuomilehto et al observed that achieving a relatively 
conservative target of at least 210 minutes of exercise per week was associated with a 
significant reduction in the risk of diabetes, even in subjects without weight loss (9).  
Depending on initial weight and gender, the CHIP participants were able to reduce their 
weight within 4 weeks by up to 5%, which approaches the 7% weight loss goal of the ADA 
for people with diabetes. Exercise, as an integral part of the CHIP intervention, obviously 
facilitates loss of excessive weight which contributes to improvements in glycemic control 
and the need for medication (29). While a BMI >30 has been shown to double the incidence 
of sudden death, and a moderate increase in BMI can lead to a 4- to 8-fold increase in the 
risk of diabetes, in males and females, respectively, Mobley and coworkers observed the 
benefits of weight loss on cardiovascular morbidity and mortality (28). Furthermore, weight 
reduction has been shown to improve endothelial function and decreased systemic 
inflammatory reaction (30).  
While there is little disagreement about the importance of a sensible and consistent activity 
program in the prevention and management of diabetes, there is still considerable debate 
about the most effective therapeutic diet. Several authors and study groups have supported 
the idea that diets low in carbohydrate content yet relatively high in protein and fat may be 
more beneficial for pre-diabetics and full blown Type 2 diabetics than high carbohydrate diets 
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since they had been shown to cause hyperglycemia (31-36). Over the years, the ADA gradually 
reduced their high fat and animal protein recommendations in that they obviously contribute 
to higher lipid levels thus promoting vascular complications, the very bane of people with 
diabetes. The ADA also liberalized their once so rigid stand against the intake of sugar and 
fresh fruits and began to recommend more fresh vegetables and whole grains and more 
legumes. And yet, while some progress has been made, the current dietary guidelines 
(recommending the use of meat, poultry, fish and non-rich dairy) are still facilitating an 
atherogenic diet with up to 7% of the calories consumed coming from saturated fat which also 
bring along some 200 mg of cholesterol. The current ADA guidelines still reflect the fear of 
recommending the higher levels of carbohydrate intake, because insufficient attention has 
been paid to the fundamental difference of how the body handles the digestion and 
absorption of (1) complex vs. simple carbohydrates (starches vs sugars) and of (2) their 
unrefined vs refined counterparts (whole grains vs white flour and whole orange vs. orange 
juice). Unrefined complex carbohydrates with their usually high fiber content become 
absorbed and digested much more slowly. Thus giving the pancreas more time not to 
overreact with excessive insulin to reduce the blood glucose levels that usually raise quickly 
after a slug of sugar, as in a glass of orange juice, where the pancreas has to deal with a highly 
refined simple carbohydrate totally depleted of any fiber (37). 
The CHIP Optimal Diet is an “ad libitum”, plant-based, very low-fat, low-sugar, high-
complex-carbohydrate/low-glycemic, high-fiber regimen with low energy density. In a 22-
week clinical trial, Barnard and coworkers were able to show that such a very low-fat plant 
based, high carbohydrate (70% of calories) diet improved significantly not only the levels of 
glycemia, but also the levels of lipids and kidney function but clearly exceeded the clinical 
results of the other intervention diet formulated according to the guidelines of the ADA (38). 
A recent review concluded that the results from observational and clinical 
trials demonstrate that low-fat, unrefined plant-based diets are at least as effective as more 
conventional diabetes diets for weight reduction and glycemic control, and that they are 
significantly more effective in the management of lipid and renal function and in the cost 
and ease of meal preparation (39). 
7.2 Intensive education and curriculum 
CHIP is an intensive educational program where participants become aware of the potential 
benefits of making healthy lifestyle changes and learn how to implement them. The 
educational curriculum is structured to build progressively and incrementally the concepts 
of lifestyle medicine. Since habits are best built through daily practice, the program was 
purposely conducted on an almost every day basis over a period of 4 weeks (40). 
7.3 Social support  
The group support setting for each of the sessions provided strong social support and may 
have contributed to the low drop-out rate of 3%. 
7.4 Community setting 
In the present study we focused on public awareness within the community of Rockford to 
ensure that individuals high at risk for coronary heart disease and/or diabetes are 
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sensitized. Our experiences show that a successful health management requires an optimal 
cooperation of health players in the community. Building up a infrastructure of health-
facilitators and multiplicators in the community supports the CHIP-philosophy. Effective 
diabetes lifestyle interventions must target not only the affected individuals, but also 
families, workplaces, schools etc. Preventing this disease epidemic calls for the identification 
of culture-sensitive measures that can be applied both to the general population and to high-
risk groups. The CHIP strategy is to combine behavior-oriented prevention (e.g. optimal 
diet, physical activity) with infrastructure-oriented prevention (e.g. supportive community, 
group support) to promote positive long-term outcomes.  
8. Limitations 
Self Selection. With its goal of cultural transformation, the CHIP program purposefully 
aimed at enrolling participants who were probably more motivated and better informed 
about the need to make healthier lifestyle choices. However, the aim was to build a 
foundation with motivated people in the community, who, in turn, would become role 
models in the community-at-large.  
Short term results only and lack of control group. It is well known that short-term behavioral 
changes are subject to decay over time and long-term effectiveness as well as causality 
cannot be demonstrated without evaluating the program in a randomized controlled trial 
over an extended period. Moreover, the dimensions to which the CHIP Alumni Association 
with its refresher courses and monthly meetings can contribute to sustaining these short-
term results remain to be subject to further investigation. Even so, the current lack of a 
randomized control group should not diminish the fact that the vast majority of the 
subgroup of 758 pre-diabetics and diabetics with multiple risk factors were able to markedly 
reduce their risk profile in 4 weeks. 
9. Conclusion 
Diabetes mellitus was very common in this free-living CHIP-cohort with 35% of the individuals 
being unaware of their condition. The consistently lowered glucose levels in the pre-diabetics 
and diabetics alike, even in those whose medication dosage had been lowered, suggests that 
lifestyle changes can be effective in lowering glycemic levels and the need for medication. This 
lifestyle intervention approach used in a community setting may contribute significantly to 
reducing the incidence and prevalence of type 2 diabetes at the population level. Until long-
term evaluations, however, have been completed, it remains to be seen whether these 
improvement may prevent or merely delay the manifestation on diabetes.  
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